Artículos de revistas
Use Of Selective Serotonin Reuptake Inhibitors For Treatment Of Depression In Pregnancy And Breast-feeding [riscos E Benefícios Do Uso Dos Inibidores Seletivos Da Recaptação De Serotonina Para A Depressão Durante A Gravidez E A Lactação]
Registro en:
Revista Brasileira De Ginecologia E Obstetricia. , v. 29, n. 7, p. 331 - 334, 2007.
1007203
10.1590/S0100-72032007000700001
2-s2.0-37449025312
Autor
Nomura M.L.
Pinto E Silva J.L.C.
Institución
Resumen
[No abstract available] 29 7 331 334 Bellantuono, C., Migliarese, G., Gentile, S., Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: A systematic review (2007) Human Psychopharmacol, 22 (3), pp. 121-128 Cantilino, A., (2003) Tradução para o português e validação da Postpartum Depression Scale na população brasileira [tese], , Recife: Universidade Federal de Pernambuco; Kallen, B.A., Otterblad Olausson, P., Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol (2007) Teratol, 79 (4), pp. 301-308 Malm, H., Klaukka, T., Neuvonen, P.J., Risks associated with selective serotonin reuptake inhibitors in pregnancy (2005) Obstet Gynecol, 106 (6), pp. 1289-1296 Wen, S.W., Yang, Q., Garner, P., Fraser, W., Olatunbosun, O., Nimrod, C., Selective serotonin reuptake inhibitors and adverse pregnancy outcomes (2006) Am J Obstet Gynecol, 194 (4), pp. 961-966 Williams, M., Wooltorton, E., Paroxetine (Paxil) and congenital malformations (2005) CMAJ, 173 (11), pp. 1320-1321 Wogelius, P., Norgaard, M., Gislum, M., Pedersen, L., Munk, E., Mortensen, P.B., Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations (2006) Epidemiology, 17 (6), pp. 701-704 De Las Cuevas, C., Sanz, E.J., Safety of selective serotonin reuptake inhibitors in pregnancy (2006) Curr Drug Saf, 1 (1), pp. 17-24 Gentile, S., The safety of newer antidepressants in pregnancy and breastfeeding (2005) Drug Saf, 28 (2), pp. 137-152 Moses-Kolko, E.L., Roth, E.K., Antepartum and postpartum depression: Healthy mom, healthy baby (2004) J Am Med Womens Assoc, 59 (3), pp. 181-191 Chambers, C.D., Hernandez-Diaz, S., Van Marter, L.J., Werler, M.M., Louik, C., Jones, K.L., Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn (2006) N Engl J Med, 354 (6), pp. 579-587 Oberlander, T.F., Warburton, W., Misri, S., Aghajanian, J., Hertzman, C., Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data (2006) Arch Gen Psychiatry, 63 (8), pp. 898-906 Gentile, S., Serotonin reuptake inhibitor-induced perinatal complications (2007) Paediatr Drugs, 9 (2), pp. 97-106 Zeskind, P.S., Stephens, L.E., Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior (2004) Pediatrics, 113 (2), pp. 368-375 Weissman, M.M., Wickramaratne, P., Nomura, Y., Warner, V., Pilovsky, D., Verdeli, H., Offspring of depressed parents: 20 years later (2006) Am J Psychiatry, 163 (6), pp. 1001-1008 Nulman, I., Rovet, J., Stewart, D.E., Wolpin, J., Pace-Asciak, P., Shuhaiber, S., Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study (2002) Am J Psychiatry, 159 (11), pp. 1889-1895 Cohen, L.S., Altshuler, L.L., Harlow, B.L., Nonacs, R., Newport, D.J., Viguera, A.C., Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment (2006) JAMA, 295 (5), pp. 499-507 Austin, M.P., To treat or not to treat: Maternal depression, SSRI use in pregnancy and adverse neonatal effects (2006) Psychol Med, 36 (12), pp. 1663-1670